• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.

作者信息

Kunz Lisette I Z, Ten Hacken Nick H, Lapperre Thérèse S, Timens Wim, Kerstjens Huib A M, van Schadewijk Annemarie, Vonk Judith M, Sont Jacob K, Snoeck-Stroband Jiska B, Postma Dirkje S, Sterk Peter J, Hiemstra Pieter S

机构信息

Dept of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.

Dept of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

Eur Respir J. 2017 Jun 15;49(6). doi: 10.1183/13993003.00848-2017. Print 2017 Jun.

DOI:10.1183/13993003.00848-2017
PMID:28619964
Abstract
摘要

相似文献

1
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.长期停用吸入性糖皮质激素后慢性阻塞性肺疾病患者的气道炎症
Eur Respir J. 2017 Jun 15;49(6). doi: 10.1183/13993003.00848-2017. Print 2017 Jun.
2
Airway inflammation and inhaled corticosteroids in COPD.慢性阻塞性肺疾病中的气道炎症与吸入性糖皮质激素
Eur Respir J. 2017 Jun 15;49(6). doi: 10.1183/13993003.00289-2017. Print 2017 Jun.
3
Through a glass darkly: inhaled corticosteroids, airway inflammation and COPD.
Eur Respir J. 2017 Jan 3;49(1). doi: 10.1183/13993003.02201-2016. Print 2017 Jan.
4
Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.吸入性糖皮质激素在慢性阻塞性肺疾病中的益处与风险
Drug Saf. 2002;25(1):57-71. doi: 10.2165/00002018-200225010-00005.
5
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.COPD 患者长期停用吸入性皮质类固醇后气道炎症。
Eur Respir J. 2017 Jan 3;49(1). doi: 10.1183/13993003.00839-2016. Print 2017 Jan.
6
Pinellia ternata Attenuates Mucus Secretion and Airway Inflammation after Inhaled Corticosteroid Withdrawal in COPD Rats.半夏可减轻慢性阻塞性肺疾病大鼠吸入性糖皮质激素撤药后的黏液分泌和气道炎症。
Am J Chin Med. 2016;44(5):1027-41. doi: 10.1142/S0192415X16500579. Epub 2016 Jul 19.
7
[Clinical efficacy of inhaled corticosteroids in COPD].吸入性糖皮质激素在慢性阻塞性肺疾病中的临床疗效
Nihon Rinsho. 2007 Apr;65(4):696-701.
8
Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis.吸入性糖皮质激素对稳定期慢性阻塞性肺疾病痰液细胞计数的影响：一项系统评价和荟萃分析。
BMC Pulm Med. 2005 Feb 11;5:3. doi: 10.1186/1471-2466-5-3.
9
[Corticosteroids for treatment of patients with chronic obstructive pulmonary disease].[皮质类固醇用于慢性阻塞性肺疾病患者的治疗]
Nihon Rinsho. 2003 Dec;61(12):2181-6.
10
[The effects of inhaled steroids withdrawal in COPD].[吸入性类固醇撤药对慢性阻塞性肺疾病的影响]
Rev Mal Respir. 2017 Oct;34(8):820-833. doi: 10.1016/j.rmr.2016.10.880. Epub 2017 May 12.

引用本文的文献

1
Extracellular vesicles from bronchoalveolar lavage fluid provide insights into the inhaled corticosteroids treatment response in COPD.支气管肺泡灌洗液体外泌体为慢性阻塞性肺疾病吸入糖皮质激素治疗反应提供了见解。
Respir Res. 2025 Jul 30;26(1):254. doi: 10.1186/s12931-025-03330-6.
2
Inflammatory cells and remodeling in bronchial biopsies from COPD patients and controls.慢性阻塞性肺疾病（COPD）患者及对照组支气管活检中的炎症细胞与重塑
PLoS One. 2025 Jun 17;20(6):e0326267. doi: 10.1371/journal.pone.0326267. eCollection 2025.
3
Eosinophils and therapeutic responses to steroids and biologics in COPD: a complex relationship.
嗜酸性粒细胞与慢性阻塞性肺疾病（COPD）中对类固醇和生物制剂的治疗反应：一种复杂的关系。
J Bras Pneumol. 2023 Dec 22;49(6):e20230360. doi: 10.36416/1806-3756/e20230360.
4
Inhaled Corticosteroids and the Risk of Lung Cancer in Chronic Obstructive Pulmonary Disease Patients: A Systematic Review and Meta-Analysis.吸入性皮质类固醇与慢性阻塞性肺疾病患者肺癌风险：系统评价和荟萃分析。
Pulm Med. 2022 Aug 21;2022:9799858. doi: 10.1155/2022/9799858. eCollection 2022.
5
Epithelial Barrier Dysfunction in Chronic Respiratory Diseases.慢性呼吸道疾病中的上皮屏障功能障碍
Front Physiol. 2021 Jun 24;12:691227. doi: 10.3389/fphys.2021.691227. eCollection 2021.
6
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.高风险慢性阻塞性肺疾病门诊患者中的他汀类药物：对首次加重时间和全因死亡率无影响 - STATUETTE 队列研究。
Int J Chron Obstruct Pulmon Dis. 2021 Mar 5;16:579-589. doi: 10.2147/COPD.S296472. eCollection 2021.
7
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes.新型冠状病毒肺炎与慢性阻塞性肺疾病：基础科学与临床结局的叙述性综述。
Eur Respir Rev. 2020 Nov 5;29(158). doi: 10.1183/16000617.0199-2020. Print 2020 Dec 31.
8
A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.关于在慢性阻塞性肺疾病的临床实践中撤回吸入性皮质类固醇的建议。
Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y.